These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 9218725)

  • 1. Li-Fraumeni syndrome--a molecular and clinical review.
    Varley JM; Evans DG; Birch JM
    Br J Cancer; 1997; 76(1):1-14. PubMed ID: 9218725
    [No Abstract]   [Full Text] [Related]  

  • 2. [p53 transgenic and knockout mice].
    Oda H
    Nihon Rinsho; 2000 Jun; 58(6):1250-4. PubMed ID: 10879049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Li-Fraumeni versus Pseudo-Li-Fraumeni Syndrome: Key Insights for Interpreting Next-Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes.
    Sorscher S; Desnoyers R; Ouyang K; Ramkissoon S
    Oncologist; 2017 Sep; 22(9):1084-1085. PubMed ID: 28592622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chronic myeloid leukemia-like syndrome case with del (12) (p12) in a Li-Fraumeni syndrome family.
    Guran S; Beyan C; Nevruz O; Yakicier C; Tunca Y
    Clin Lab Haematol; 2005 Apr; 27(2):135-8. PubMed ID: 15784129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome.
    Turner SA; Shaver AC; Kovach AE; Oluwole OO; Mason EF
    Leuk Lymphoma; 2019 Dec; 60(13):3312-3315. PubMed ID: 31230491
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
    Varley JM; McGown G; Thorncroft M; White GR; Tricker KJ; Kelsey AM; Birch JM; Evans DG
    Br J Cancer; 1998 Oct; 78(8):1081-3. PubMed ID: 9792154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.
    Upton B; Chu Q; Li BD
    Surg Oncol Clin N Am; 2009 Jan; 18(1):145-56, ix. PubMed ID: 19056046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.
    Kuperwasser C; Hurlbut GD; Kittrell FS; Dickinson ES; Laucirica R; Medina D; Naber SP; Jerry DJ
    Am J Pathol; 2000 Dec; 157(6):2151-9. PubMed ID: 11106587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
    Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
    Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2009 version of the Chompret criteria for Li Fraumeni syndrome.
    Tinat J; Bougeard G; Baert-Desurmont S; Vasseur S; Martin C; Bouvignies E; Caron O; Bressac-de Paillerets B; Berthet P; Dugast C; Bonaïti-Pellié C; Stoppa-Lyonnet D; Frébourg T
    J Clin Oncol; 2009 Sep; 27(26):e108-9; author reply e110. PubMed ID: 19652052
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a novel TP53 germline mutation in a large Italian Li-Fraumeni syndrome Family.
    Capra V; Consales A; Nozza P; Monti P; Inga A; Fronza G
    Pediatr Blood Cancer; 2009 Feb; 52(2):303-4. PubMed ID: 18937320
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical and imaging surveillance in Li-Fraumeni syndrome.
    Raskind WH; Hisama FM; Bennett RL
    Lancet Oncol; 2016 Nov; 17(11):e472. PubMed ID: 27819239
    [No Abstract]   [Full Text] [Related]  

  • 13. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
    Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and stochastic influences upon tumor formation and tumor types in Li-Fraumeni mouse models.
    Chan CS; Sun Y; Ke H; Zhao Y; Belete M; Zhang C; Feng Z; Levine AJ; Hu W
    Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376133
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and imaging surveillance in Li-Fraumeni syndrome - Authors' reply.
    Villani A; Malkin D
    Lancet Oncol; 2016 Nov; 17(11):e473. PubMed ID: 27819240
    [No Abstract]   [Full Text] [Related]  

  • 16. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene].
    Leblanc T; Soussi T
    Arch Pediatr; 1994 Jan; 1(1):61-70. PubMed ID: 8087224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline TP53 mutations and Li-Fraumeni syndrome.
    Varley JM
    Hum Mutat; 2003 Mar; 21(3):313-20. PubMed ID: 12619118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Li-Fraumeni syndrome really much more common?
    Thomas DM
    Hum Mutat; 2017 Dec; 38(12):1619. PubMed ID: 29091331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.